...
首页> 外文期刊>Der chemica Sinica >Synthesis, characterization and antimicrobial activity of novel mannich bases of indol derivatives
【24h】

Synthesis, characterization and antimicrobial activity of novel mannich bases of indol derivatives

机译:吲哚衍生物新型曼尼希碱的合成,表征和抗菌活性

获取原文
           

摘要

New novel derivatives of 2-(5-chloro-3-(4-substituted phenylimino)methyl)-1-(pyridine-4-yl)-1H-pyrazol-3-yl)-1Hindol- 1-yl)-N1-(2-oxo-1-(4-substituted piperidin-1-ylmethyl)indolin-3-ylidene) acetohydrazide 9(a-o) were prepared by the (mannich reaction) condensation of 2-(5-chloro-3-(4-substituted phenylimino)methyl)-1-(pyridin-4-yl)-1Hpyrazol- 3-yl)-1H-indol-1-yl)N1-(2-oxoindolin-3-ylidene)acetohydrazide 8(a-e) with piper dine/morpholine/Nmethyl piperizine and formaldehyde in DMF. The compounds 8(a-e) were obtained by the reaction of 2-(5-chloro-3- (4-substituted phenylimino)methyl)-1-(pyridin-4-yl)-1H-pyrazol-3-yl) 1H-indol-1-yl)acetohydrazaide 7(a-e) with isatin. Subsequently 7(a-e) were obtained by the reaction of ethyl-2-(5-chloro-3-(4-substituted phenylimino)methyl)- 1-(pyridin-4-yl) -1H-pyrazol-3-yl)-1H-indol-1-yl)acetate 6(a-e) with hydrazine hydrate. The synthon 6(a-e) were obtained by the reaction of ethyl-2-(5-cloro-3-(4-formyl-1-(pyridine-4-yl)-1H-pyrazol-3-yl)-1H-indol-1-yl)acetate(5) with 4-substituted anilines. The compound (5) was obtained by the Vilsmeier-Haack reaction of 2-(5-chloro-3-(1- (2-pyridin-4-yl)hydrazono)ethyl)-1H-indol-1-yl)acetate (4) at 0-50C. The 2-(5-chloro-3-(1-(2-pyridin-4- yl)hydrazono)ethyl)-1H-indol-1-yl)acetate (4) was obtained by reaction of 1-(5-chloro-1H-indol-3-yl)ethanone (1) with chloro ethyl acetate in K2CO3 and DMF, the product obtained in the reaction is further treated with 4- hydrazino pyridine. Finally the title of the compounds 9(a-o) were subjected to antimicrobial studies and incorporated in the present studies. All the compounds were characterized by spectral studies (IR, 1H-NMR, 13CNMR, Mass) and Elemental analysis.
机译:2-(5-氯-3-(4-取代的苯基亚氨基)甲基)-1-(吡啶-4-基)-1H-吡唑-3-基)-1Hindol-1-基)-N1-的新的新型衍生物(2-氧代-1-(4-取代的哌啶-1-基甲基)吲哚-3-亚基)乙酰肼9(ao)通过2-(5-氯-3-(4-哌啶取代取代的苯基亚氨基)甲基)-1-(吡啶-4-基)-1吡唑-3-基)-1H-吲哚-1-基)N1-(2-氧吲哚-3-亚基)乙酰肼8(ae) /吗啉/ N甲基哌嗪和甲醛在DMF中的含量。通过2-(5-氯-3-(4-取代的苯基亚氨基)甲基)-1-(吡啶-4-基)-1H-吡唑-3-基)1H-的反应获得化合物8(ae)。吲哚-1-基)乙酰肼7(ae)与靛红。随后,通过乙基-2-(5-氯-3-(4-取代的苯基亚氨基)甲基)-1-(吡啶-4-基)-1H-吡唑-3-基)-的反应获得7(ae)。 1H-吲哚-1-基)乙酸盐6(ae)与水合肼。通过乙基-2-(5-氯-3-(4-甲酰基-1-(吡啶-4-基)-1H-吡唑-3-基)-1H-吲哚的反应获得合成子6(ae)。具有4-取代苯胺的-1-乙酸基酯(5)化合物(5)通过2-(5-氯-3-(1-(2-吡啶-4-基)肼基)乙基)-1H-吲哚-1-基)乙酸酯的Vilsmeier-Haack反应获得( 4)在0-50C。 2-(5-氯-3-(1-(2-吡啶-4-基)肼基)乙基)-1H-吲哚-1-基)乙酸酯(4)是通过1-(5-氯-1H-吲哚-3-基)乙酮(1)与氯乙酸乙酯在K2CO3和DMF中的反应中获得的产物进一步用4-肼基吡啶处理。最后,对化合物9(a-o)的标题进行了抗菌研究,并纳入了本研究。所有化合物均通过光谱研究(IR,1H-NMR,13CNMR,质谱)和元素分析进行​​了表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号